Chinese authorities have expressed firm opposition to the passing of the Strategic Competition Act of 2021 by the U.S. Senate Committee on Foreign Relations.

中国有关部门坚决反对美国参议院外交关系委员会通过的《2021战略竞争法案》。

The government made it clear that the Competition Act—which prohibits anti-competitive agreements and the abuse of a dominant market position—should be applied to the NHS.

竞争法令—禁止反竞争合同和滥用市场垄断地位—应用于国民医保系统。